The synergy of KP372-1 + PARPi that increased efficacy in killing NQO1+ cancer cells and enhanced KP372-1 effects on cancer cell death occurred through AKT hyperactivation and induction of increased DNA damage, and the combination therapy caused more autophagic cell death than KP372-1 treatment alone (Figure 5D). The gene discussed is AKT1; the disease is cancer.